Searched for
WILL SMITH THERAPY
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...- Top cases on the United States Supreme Court's docketThe U.S. Supreme Court is reviewing significant cases. These cases cover voting rights, presidential authority, immigration policies, and g...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- Did Ancient Egyptian Doctors Use Breast Milk to Treat Eye Problems? A New Look at a 3,500-Year-Old Medical MysteryAncient Egyptian physicians documented treatments on papyrus, revealing a sophisticated medical system. While most eye treatments involved ...
- Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhalerGlenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step i...
- GSK enters into oncology segment; launches therapies for gynaecological cancersGlaxoSmithKline Pharmaceuticals has entered the oncology segment in India, introducing Jemperli and Zejula for gynaecological cancers. Thes...
- Robert de Niro's daughter Airyn de Niro comes out as trans, reveals details about her transition journeyLegendary Hollywood actor Robert de Niro's daughter Airyn de Niro recently came out as transgender. In an interview, she provided insights ...
- Pharma market picks up pace, sees 10% value growth in NovIndia's pharmaceutical market rebounded in November with 9.9% value growth and 3.1% volume growth. Key therapy areas like cardiac, gastroin...
- GSK Pharma to expand into oncology, focus on adult vaccines in IndiaGlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and oncology in Indi...
- What's in store for Mr. & Mrs. Smith Season 2? Here’s what we know so farExploring the potential for a second season, the thrilling narrative, and the fate of John and Jane Smith in the hit series "Mr. & Mrs. Smi...
- GlaxoSmithKline Pharma Q1 Results: Net profit rises 11% to Rs 132 crDespite the strong external headwinds, GSK remains focused on delivering best-in-class competitive performance and driving operational effi...
- GSK India reports Rs 133 crore net profit in quarter four of FY23GSK India reported a net profit of Rs 133 crore for the quarter ended March 31, 2023, with continued momentum across general medicines and ...
- A month after Oscars slapgate, Will Smith hits therapy mode; may appear on David Letterman's chat showDuring the Oscars 2022, Smith slapped comedian Chris Rock for cracking a joke on his wife, Jada.
- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- AstraZeneca says antibody treatment failed in preventing COVID-19 in exposed patientsThe company said the participants in the trial were unvaccinated adults older than 18 years with confirmed exposure to a person with the co...
- Michael Jackson's daughter Paris gets honest about her life under the media glare, says paparazzi caused her long-term traumaEarlier, Jackson had revealed self-harm and suicide attempts, and said music was a way to channel her pain.
- Add GSK Pharmaceuticals, target price Rs 1575: ICICI SecuritiesGlaxoSmithKline Pharmaceuticals Ltd., incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 24477.48 Crore) oper...
- Dr Reddy's sells two neurology products in $110 mn dealDr Reddy's will receive $ 70 mn as upfront consideration, $40.5 mn in near-term milestones.
- Focus on 20 key brands to drive growth: GlaxoSmithKline pharmaceuticalsAs part of its growth plans the company is also planning to aggressively expand its field force.
- Suresh Subramanian to head Biocon's branded formulations bizSuresh has over 30 years of experience in the pharmaceuticals market, having worked in India and Thailand for MNCs such as GlaxoSmithKline,...
Load More
